Baseline characteristics of CACE-I, NoCACE-I or NewCACE-I patients
| Groups | CACE-I | NoCACE-I | NewCACE-I |
|---|---|---|---|
| Number | 85 | 276 | 30 |
| Age (mean±SD) | 77.2±6.4 | 77.0±7.6 | 77.3±8.2 |
| Male (%) | 44 (51.8) | 137 (49.6) | 15 (50) |
| Education (mean±SD) | 10.6±3.8 | 11.4±4.0 | 12.1±3.9 |
| Systolic BP in mm Hg (mean±SD) | 133.4±21.2 | 135.5±16.9 | 141.1±16.2 |
| Diastolic BP in mm Hg (mean±SD) | 70.1±12.6 | 72.5±11.5 | 78.1±17.0 |
| Cholinesterase inhibitor use (%) | 75 (88.2) | 228 (82.6) | 24 (80) |
| Memantine use (%) | 23 (27.1) | 72 (26.1) | 8 (26.7) |
BP, blood pressure; CACE-I, patients currently receiving ACE inhibitors; NewCACE-I, patients who were newly started on CACE-Is; NoCACE-I, patients who are not currently prescribed CACE-Is.